Exclusive: Arlington closes $1.45bn sale of Riverpoint Medical to Novanta

'Broadly speaking, we see a very stable, conducive transaction environment across the healthcare landscape heading into the back half of this year,' Arlington managing partner Matt Altman told PE Hub.